Medical Engineering Services Ltd 07353811 false 2024-09-01 2025-08-30 2025-08-30 The principal activity of the company is the supply and installation of dental and medical equipment. Digita Accounts Production Advanced 6.30.9574.0 true true 07353811 2024-09-01 2025-08-30 07353811 2025-08-30 07353811 bus:OrdinaryShareClass1 bus:CumulativeShares 2025-08-30 07353811 2 2025-08-30 07353811 core:CurrentFinancialInstruments 2025-08-30 07353811 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-30 07353811 core:Non-currentFinancialInstruments 2025-08-30 07353811 core:Non-currentFinancialInstruments core:AfterOneYear 2025-08-30 07353811 core:FurnitureFittingsToolsEquipment 2025-08-30 07353811 core:LandBuildings 2025-08-30 07353811 core:MotorVehicles 2025-08-30 07353811 core:OtherPropertyPlantEquipment 2025-08-30 07353811 1 2025-08-30 07353811 bus:SmallEntities 2024-09-01 2025-08-30 07353811 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-30 07353811 bus:FilletedAccounts 2024-09-01 2025-08-30 07353811 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-30 07353811 bus:RegisteredOffice 2024-09-01 2025-08-30 07353811 bus:Director1 2024-09-01 2025-08-30 07353811 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-09-01 2025-08-30 07353811 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-30 07353811 core:FurnitureFittingsToolsEquipment 2024-09-01 2025-08-30 07353811 core:LandBuildings 2024-09-01 2025-08-30 07353811 core:MotorVehicles 2024-09-01 2025-08-30 07353811 core:OfficeEquipment 2024-09-01 2025-08-30 07353811 core:OtherPropertyPlantEquipment 2024-09-01 2025-08-30 07353811 core:PlantMachinery 2024-09-01 2025-08-30 07353811 countries:EnglandWales 2024-09-01 2025-08-30 07353811 1 2024-09-01 2025-08-30 07353811 2024-08-31 07353811 core:FurnitureFittingsToolsEquipment 2024-08-31 07353811 core:LandBuildings 2024-08-31 07353811 core:MotorVehicles 2024-08-31 07353811 core:OtherPropertyPlantEquipment 2024-08-31 07353811 1 2024-08-31 07353811 2023-09-01 2024-08-31 07353811 2024-08-31 07353811 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-08-31 07353811 2 2024-08-31 07353811 core:CurrentFinancialInstruments 2024-08-31 07353811 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 07353811 core:Non-currentFinancialInstruments 2024-08-31 07353811 core:Non-currentFinancialInstruments core:AfterOneYear 2024-08-31 07353811 core:FurnitureFittingsToolsEquipment 2024-08-31 07353811 core:LandBuildings 2024-08-31 07353811 core:MotorVehicles 2024-08-31 07353811 core:OtherPropertyPlantEquipment 2024-08-31 07353811 1 2024-08-31 07353811 1 2023-09-01 2024-08-31 07353811 1 2023-08-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 07353811

Medical Engineering Services Ltd

Unaudited Filleted Financial Statements

for the Period from 1 September 2024 to 30 August 2025

 

Medical Engineering Services Ltd

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 7

 

Medical Engineering Services Ltd

(Registration number: 07353811)
Balance Sheet as at 30 August 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

14,052

17,182

Current assets

 

Stocks

266,591

114,223

Debtors

5

242,981

254,510

Cash at bank and in hand

 

40,800

72,056

 

550,372

440,789

Creditors: Amounts falling due within one year

6

(429,741)

(323,491)

Net current assets

 

120,631

117,298

Total assets less current liabilities

 

134,683

134,480

Creditors: Amounts falling due after more than one year

6

(222,044)

(114,694)

Provisions for liabilities

(3,925)

(3,925)

Net (liabilities)/assets

 

(91,286)

15,861

Capital and reserves

 

Called up share capital

7

100

100

Retained earnings

(91,386)

15,761

Shareholders' (deficit)/funds

 

(91,286)

15,861

For the financial period ending 30 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 21 August 2026 and signed on its behalf by:
 

.........................................
Mr J P Youds
Director

 

Medical Engineering Services Ltd

Notes to the Unaudited Financial Statements for the Period from 1 September 2024 to 30 August 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
DE:UK
Cunliffe Road
Blackburn
Lancashire
BB1 5UA

These financial statements were authorised for issue by the Board on 21 August 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Medical Engineering Services Ltd

Notes to the Unaudited Financial Statements for the Period from 1 September 2024 to 30 August 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Property improvements

10% per annum reducing balance basis

Fixtures and fittings

33% per annum reducing balance basis

Office equipment

15% per annum reducing balance basis

Motor vehicles

20% per annum reducing balance basis

Plant and machinery

15% per straight line balance basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Medical Engineering Services Ltd

Notes to the Unaudited Financial Statements for the Period from 1 September 2024 to 30 August 2025

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 10 (2024 - 8).

 

Medical Engineering Services Ltd

Notes to the Unaudited Financial Statements for the Period from 1 September 2024 to 30 August 2025

4

Tangible assets

Property improvements
£

Fixtures, fittings and equipment
 £

Motor vehicles
 £

Plant and machinery
£

Total
£

Cost

At 1 September 2024

3,965

27,744

6,659

15,763

54,131

At 30 August 2025

3,965

27,744

6,659

15,763

54,131

Depreciation

At 1 September 2024

1,447

16,582

3,552

15,368

36,949

Charge for the period

252

1,862

621

395

3,130

At 30 August 2025

1,699

18,444

4,173

15,763

40,079

Carrying amount

At 30 August 2025

2,266

9,300

2,486

-

14,052

At 31 August 2024

2,518

11,162

3,107

395

17,182

 

Medical Engineering Services Ltd

Notes to the Unaudited Financial Statements for the Period from 1 September 2024 to 30 August 2025

5

Debtors

2025
£

2024
£

Trade debtors

108,743

123,732

Other debtors

89,489

107,595

Corporation tax recoverable

44,749

23,183

242,981

254,510

6

Creditors

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

8

67,006

59,841

Trade creditors

 

156,407

107,273

Taxation and social security

 

159,178

120,723

Accruals and deferred income

 

-

35,654

Other creditors

 

47,150

-

 

429,741

323,491

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

8

222,044

114,694

7

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

       
 

Medical Engineering Services Ltd

Notes to the Unaudited Financial Statements for the Period from 1 September 2024 to 30 August 2025

8

Loans and borrowings

Non-current loans and borrowings

2025
£

2024
£

Bank borrowings

222,044

114,694

Current loans and borrowings

2025
£

2024
£

Bank borrowings

67,006

59,827

Bank overdrafts

-

14

67,006

59,841

9

Related party transactions

Transactions with directors

2025

At 1 September 2024
£

Repayments by director
£

At 30 August 2025
£

Loans to directors

93,711

(4,223)

89,488

 

2024

At 1 September 2023
£

Advances to director
£

At 31 August 2024
£

Loans to directors

70,519

23,192

93,711